AMNEAL PHARMACEUTICALS, INC. (AMRX) Return on equity 2018–2023
AMNEAL PHARMACEUTICALS, INC. (AMRX) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-424.6%FY2023 · since FY2018: -3.9% → -424.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2023 | -424.6% | -333.9 pp |
| FY2022 | -90.7% | -94.3 pp |
| FY2021 | 3.7% | -18.7 pp |
| FY2020 | 22.4% | +282.5 pp |
| FY2019 | -260.1% | -256.2 pp |
| FY2018 | -3.9% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice